# A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease

> **NCT01016951** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 36 (estimated)

## Conditions studied

- Healthy
- COPD

## Interventions

- **DRUG:** AZD9164 Turbuhaler®
- **DRUG:** Placebo Turbuhaler®

## Key facts

- **NCT ID:** NCT01016951
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 36 (ESTIMATED)
- **Why stopped:** Study stopped since it was considered that one of the pre-defined stopping criterion was met.
- **Last updated:** 2010-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016951, "A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01016951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*